Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank75
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
12.72%
↑ 205% vs avg
Percentile
P75
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-12.13%
Historical baseline
PeriodValue
Q4 202512.72%
Q3 202514.66%
Q2 2025-2.52%
Q1 202513.76%
Q4 202413.13%
Q3 2024-37.37%
Q2 2024-30.17%
Q1 2024-29.19%
Q4 2023-7.16%
Q3 2023-87.46%
Q2 20233.70%
Q1 2023-38.96%
Q4 2022-35.86%
Q3 2022-3.07%
Q2 202214.40%
Q1 2022-6.86%
Q4 20210.00%